Embolization Market- Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Embolization Market |
Researchers and key players are
focusing on the development of novel embolization products for the treatment of
chronic diseases such as tumour, haemorrhage, and others, which will drive
growth in the global embolization market over the forecast period. For example,
MicroVention, Inc., a Terumo subsidiary and global neurovascular company,
received FDA approval in January 2021 for its PMA Supplement for the WEB 17
System, a new addition to the WEB Aneurysm Embolization System for the
treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System is
built with the most recent MicroBraid technology and includes a lower profile
delivery system that is compatible with the VIA 17 microcatheter as well as
additional device configurations.
The global Embolization
Market is estimated to be valued at US$ 1,433.6 million in 2020 and
is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).
Over the forecast period, the
rising prevalence of chronic diseases such as cancer, cardiovascular disease,
neurovascular disease, and others is expected to drive growth in the global
embolization market. For example, according to World Health Organization
statistics published in March 2021, cancer is the second leading cause of death
worldwide, accounting for approximately 10 million deaths per year, and
accounting for approximately one in every six deaths. Furthermore, according to
the same source, an estimated 9.6 million people died from cancer in 2018.
Furthermore, the prevalence of
ischemic heart disease is increasing, according to the Global Burden of Disease
(GBD), an article published in the National Center for Biotechnology
Information (NCBI) in July 2020. According to the GBD datasets, the prevalence
rate of ischemic heart disease was 1,655 per 100,000 global population in 2020
and is expected to exceed 1,845 by 2030. Furthermore, according to the Brain
Aneurysm Foundation report 2020, brain aneurysms cause nearly 500,000 deaths
worldwide each year, with half of the victims being under the age of 50.
Embolization Market Divisions-
·
Product
Type: Particles (Radioembolization Spheres, Drug-Eluting Beads,
Microspheres (or Blands beads, without drug), PVA particles (Polyvinyl
Alcohol)), Liquid Embolic, Plugs, Coils
·
Indication:
Hemorrage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor
(Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous
embolization (incl. Varicocele for ex), Others
·
End User:
Hospitals & Clinics, Ambulatory Surgical Centers, Others
Comments
Post a Comment